United-Guardian, Inc. (UG) Stock | UG Stock Price & Analysis

Feed

United-Guardian, Inc. UG · NASDAQ

$6.66 -2.70% (-$0.19)

Summary

76 / 100 · Bulios Score

Valuation 92Growth 9Profitability 100Quality 89Debt 100Stability 62

What speaks for it

Out of every 100 USD of revenue, 22 USD is left as net profit.
It has no debt and holds $1.63M in cash.
It earns 16 USD a year on every 100 USD of invested capital.

What to watch

Revenue fell by 6.0% a year over the last 3 years.
The share price is above the Bulios Fair Price.
It pays out more in dividends than it earns: 102% of profit.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Looks expensive

Bulios Fair Price

Current price $6.66

5-year average P/E 14.9 17% lower

P/E today 12.4

Household & Personal Products industry median

P/E today 12.4

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 12.4 USD for 1 USD of yearly profit. Over the last five years it was 14.9 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

14M

13M

11M

12M

11M

20212022202320242025

Diluted EPS (USD)

$1.01

$0.56

$0.71

$0.46

20212022202320242025

Revenue fell by 0.8% a year over 5 years. Over the last 3 years it fell by 6.0% a year. Earnings per share fell by 6.3% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Cost of sales 54 USD
Research and development 4.3 USD
Sales and administration 21 USD
Taxes and other -1.2 USD
Net profit 22 USD

Net profit, industry median (Household & Personal Products) 9.0 USD

Out of every 100 USD of revenue, 22 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Cash and short-term investments $8.93M

Debt $0.00

Free cash flow over 12 months $3.33M

It has no debt.

Financial health in detail

Does it pay a dividend?

High, at risk

1.13

0.68

0.10

0.60

20212022202320242025

Yield: 8.26%
Paid out of profit: 102%

You receive $0.55 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

Fiscal year 2016

By product

Personal Care 44%
Pharmaceuticals 31%
Medical 24%
Industrial And Other 1.4%

By region

The company reports no revenue by region.

Personal Care brings in 44% of revenue. Pharmaceuticals grew fastest, by 23% a year.

Segments in detail